Drug intelligence / Profile preview

clotrimazole + betamethasone dipropionate + neomycin sulfate

Development stage
Preclinical
Lead developer
PSA Chemicals and Pharmaceutical
Modality
Small Molecules
Administration
Topical
01

Overview

Clotrimazole + betamethasone dipropionate + neomycin sulfate is a triple-combination topical cream developed by PSA Chemicals and Pharmaceutical Pvt. Ltd. (PSA Chem). This small molecule formulation combines three active ingredients to address complex skin conditions involving inflammation, fungal infection, and bacterial infection. Clotrimazole (1%) is an azole antifungal that inhibits the synthesis of ergosterol, a vital component of fungal cell membranes. Betamethasone dipropionate (0.05%) is a potent synthetic corticosteroid that provides anti-inflammatory, antipruritic, and vasoconstrictive effects by inhibiting the release of inflammatory mediators like prostaglandins. Neomycin sulfate (0.5%) is an aminoglycoside antibiotic that inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. The cream is primarily indicated for the treatment of inflammatory dermatoses, including psoriasis, and skin infections where multiple pathogenic factors are present.

Brand names
Surfaz-SN Triple Action Cream
Other names
Clotrimazole + Betamethasone + Neomycin creamcombination topical cream
02

Targets

GR (Glucocorticoid receptor)CYP51A1 (Sterol 14α-demethylase)Bacterial Ribosome

Beyond the preview

Go deeper on clotrimazole + betamethasone dipropionate + neomycin sulfate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on clotrimazole + betamethasone dipropionate + neomycin sulfate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call